The DOI matches its Crossref record; 100 of the 100 references it cites were found in a registry or an index.
Immunogenicity of biologically-derived therapeutics: Assessment and interpretation of nonclinical safety studies
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Guide for the Care and Use of Laboratory Animals: Eighth Edition
(2011) · doi:10.17226/12910 · Cited by 16,199
Antibodies, a laboratory manual
(1989) · Biomedicine & Pharmacotherapy · doi:10.1016/0753-3322(89)90130-3 · Cited by 12,366
The 1996 Guide for the Care and Use of Laboratory Animals
Clark, J. D., Gebhart, G. F., Gonder, J. C., Keeling, M. E., & Kohn, D. F. (1997) · ILAR Journal · doi:10.1093/ilar.38.1.41 · Cited by 4,417
Vignali, D. A. A., Collison, L. W., & Workman, C. J. (2008) · Nature Reviews Immunology · doi:10.1038/nri2343 · Cited by 3,463
PEGylation, successful approach to drug delivery
Veronese, F. M., & Pasut, G. (2005) · Drug Discovery Today · doi:10.1016/s1359-6446(05)03575-0 · Cited by 2,339
Predominant Autoantibody Production by Early Human B Cell Precursors
Wardemann, H., Yurasov, S., Schaefer, A., Young, J. W., Meffre, E., & Nussenzweig, M. C. (2003) · Science · doi:10.1126/science.1086907 · Cited by 2,083
Influence of Immunogenicity on the Long-Term Efficacy of Infliximab in Crohn's Disease
Baert, F., Noman, M., Vermeire, S., Van Assche, G., D' Haens, G., Carbonez, A., & Rutgeerts, P. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa020888 · Cited by 2,015
Regulatory T Cell Clones Induced by Oral Tolerance: Suppression of Autoimmune Encephalomyelitis
Chen, Y., Kuchroo, V. K., Inobe, J.-I., Hafler, D. A., & Weiner, H. L. (1994) · Science · doi:10.1126/science.7520605 · Cited by 1,973
Glycosylation and the Immune System
Rudd, P. M., Elliott, T., Cresswell, P., Wilson, I. A., & Dwek, R. A. (2001) · Science · doi:10.1126/science.291.5512.2370 · Cited by 1,588
Effects of protein aggregates: An immunologic perspective
Rosenberg, A. S. (2006) · The AAPS Journal · doi:10.1208/aapsj080359 · Cited by 1,355
Casadevall, N., Nataf, J., Viron, B., Kolta, A., Kiladjian, J.-J., Martin-Dupont, P., Michaud, P., Papo, T., Ugo, V., Teyssandier, I., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa011931 · Cited by 1,246
The Induction of Tolerance by Dendritic Cells That Have Captured Apoptotic Cells
Steinman, R. M., Turley, S., Mellman, I., & Inaba, K. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.3.411 · Cited by 1,172
Molberg, Ø., Mcadam, S. N., Körner, R., Quarsten, H., Kristiansen, C., Madsen, L., Fugger, L., Scott, H., Norén, O., Roepstorff, P., et al. (1998) · Nature Medicine · doi:10.1038/nm0698-713 · Cited by 1,168
Cross-Presentation, Dendritic Cells, Tolerance and Immunity
Heath, W. R., & Carbone, F. R. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.47 · Cited by 882
Origin of regulatory T cells with known specificity for antigen
Apostolou, I., Sarukhan, A., Klein, L., & von Boehmer, H. (2002) · Nature Immunology · doi:10.1038/ni816 · Cited by 847
Peripheral deletion of antigen-reactive T cells in oral tolerance
Chen, Y., Inobe, J.-I., Marks, R., Gonnella, P., Kuchroo, V. K., & Weiner, H. L. (1995) · Nature · doi:10.1038/376177a0 · Cited by 783
Thrombocytopenia caused by the development of antibodies to thrombopoietin
Li, J., Yang, C., Xia, Y., Bertino, A., Glaspy, J., Roberts, M., & Kuter, D. J. (2001) · Blood · doi:10.1182/blood.v98.12.3241 · Cited by 683
Central tolerance: learning self-control in the thymus
Hogquist, K. A., Baldwin, T. A., & Jameson, S. C. (2005) · Nature Reviews Immunology · doi:10.1038/nri1707 · Cited by 659
Induction of anergy or active suppression following oral tolerance is determined by antigen dosage.
Friedman, A., & Weiner, H. L. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.14.6688 · Cited by 635
Mire-Sluis, A. R., Barrett, Y. C., Devanarayan, V., Koren, E., Liu, H., Maia, M., Parish, T., Scott, G., Shankar, G., Shores, E., et al. (2004) · Journal of Immunological Methods · doi:10.1016/j.jim.2004.06.002 · Cited by 624
Self-citationShankar, G., Devanarayan, V., Amaravadi, L., Barrett, Y. C., Bowsher, R., Finco-Kent, D., Fiscella, M., Gorovits, B., Kirschner, S., Moxness, M., et al. (2008) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2008.09.020 · Cited by 613
Self-citationB Cells Turn Off Virgin But Not Memory T Cells
Fuchs, E. J., & Matzinger, P. (1992) · Science · doi:10.1126/science.1439825 · Cited by 562
Immune responses to dietary antigens: oral tolerance
Strobel, S., & Mowat, A. M. (1998) · Immunology Today · doi:10.1016/s0167-5699(97)01239-5 · Cited by 449
Oral tolerance in experimental autoimmune encephalomyelitis. III. Evidence for clonal anergy
Whitacre, C. C., Gienapp, I. E., Orosz, C. G., & Bitar, D. M. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.147.7.2155 · Cited by 445
Activation of CD25+CD4+ Regulatory T Cells by Oral Antigen Administration
Zhang, X., Izikson, L., Liu, L., & Weiner, H. L. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.8.4245 · Cited by 445
Small B cells as antigen-presenting cells in the induction of tolerance to soluble protein antigens.
Eynon, E. E., & Parker, D. C. (1992) · The Journal of experimental medicine · doi:10.1084/jem.175.1.131 · Cited by 424
Skipper, J. C., Hendrickson, R. C., Gulden, P. H., Brichard, V, Van Pel, A., Chen, Y., Shabanowitz, J., Wolfel, T., Slingluff, C. L., Boon, T., et al. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.2.527 · Cited by 405
Gessner, J. E., Heiken, H., Tamm, A., & Schmidt, R. E. (1998) · Annals of Hematology · doi:10.1007/s002770050396 · Cited by 404
Activation of natural regulatory T cells by IgG Fc–derived peptide “Tregitopes”
De Groot, A. S., Moise, L., McMurry, J. A., Wambre, E., Van Overtvelt, L., Moingeon, P., Scott, D. W., & Martin, W. (2008) · Blood · doi:10.1182/blood-2008-02-138073 · Cited by 392
Dresser, D. W. (1962) · PubMed Central · Cited by 385
Immature, but not inactive: the tolerogenic function of immature dendritic cells
Mahnke, K., Schmitt, E., Bonifaz, L., Enk, A. H., & Jonuleit, H. (2002) · Immunology & Cell Biology · doi:10.1046/j.1440-1711.2002.01115.x · Cited by 384
Cooper, K. D., Oberhelman, L., Hamilton, T. A., Baadsgaard, O., Terhune, M., LeVee, G., Anderson, T., & Koren, H. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.18.8497 · Cited by 366
Characterizing biological products and assessing comparability following manufacturing changes
Chirino, A. J., & Mire-Sluis, A. (2004) · Nature Biotechnology · doi:10.1038/nbt1030 · Cited by 364
Ganson, N. J., Kelly, S. J., Scarlett, E., Sundy, J. S., & Hershfield, M. S. (2005) · Arthritis Research & Therapy · doi:10.1186/ar1861 · Cited by 350
Factors influencing the immunogenicity of therapeutic proteins
Schellekens, H. (2005) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfh1092 · Cited by 332
Koren, E., Smith, H. W., Shores, E., Shankar, G., Finco-Kent, D., Rup, B., Barrett, Y.-C., Devanarayan, V., Gorovits, B., Gupta, S., et al. (2008) · Journal of Immunological Methods · doi:10.1016/j.jim.2008.01.001 · Cited by 328
Self-citationKurts, C., Miller, J. F. A. P., Subramaniam, R. M., Carbone, F. R., & Heath, W. R. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.2.409 · Cited by 309
Braun, A., Kwee, L., Labow, M. A., & Alsenz, J. (1997) · Pharmaceutical Research · doi:10.1023/a:1012193326789 · Cited by 298
Meadows, L., Wang, W., den Haan, J. M. M., Blokland, E., Reinhardus, C., Drijfhout, J. W., Shabanowitz, J., Pierce, R., Agulnik, A. I., Bishop, C. E., et al. (1997) · Immunity · doi:10.1016/s1074-7613(00)80330-1 · Cited by 284
Post-translational protein modifications in antigen recognition and autoimmunity
Doyle, H. A., & Mamula, M. J. (2001) · Trends in Immunology · doi:10.1016/s1471-4906(01)01976-7 · Cited by 280
Koren, E., Zuckerman, L., & Mire-Sluis, A. (2002) · Current Pharmaceutical Biotechnology · doi:10.2174/1389201023378175 · Cited by 267
Shankar, G., Pendley, C., & Stein, K. E. (2007) · Nature Biotechnology · doi:10.1038/nbt1303 · Cited by 260
Self-citationGupta, S., Indelicato, S. R., Jethwa, V., Kawabata, T., Kelley, M., Mire-Sluis, A. R., Richards, S. M., Rup, B., Shores, E., Swanson, S. J., et al. (2007) · Journal of Immunological Methods · doi:10.1016/j.jim.2006.12.004 · Cited by 241
Self-citationThe anatomy of T-cell activation and tolerance.
Mondino, A., Khoruts, A., & Jenkins, M. K. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.6.2245 · Cited by 218
Basu, A., Yang, K., Wang, M., Liu, S., Chintala, R., Palm, T., Zhao, H., Peng, P., Wu, D., Zhang, Z., et al. (2006) · Bioconjugate Chemistry · doi:10.1021/bc050322y · Cited by 213
Isoaspartyl Post-translational Modification Triggers Autoimmune Responses to Self-proteins
Mamula, M. J., Gee, R. J., Elliott, J. I., Sette, A., Southwood, S., Jones, P.-J., & Blier, P. R. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.32.22321 · Cited by 212
Peptide-MHC potency governs dynamic interactions between T cells and dendritic cells in lymph nodes
Skokos, D., Shakhar, G., Varma, R., Waite, J. C., Cameron, T. O., Lindquist, R. L., Schwickert, T., Nussenzweig, M. C., & Dustin, M. L. (2007) · Nature Immunology · doi:10.1038/ni1490 · Cited by 205
Improving the therapeutic efficacy of peptides and proteins: A role for polysialic acids
Gregoriadis, G., Jain, S., Papaioannou, I., & Laing, P. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.06.007 · Cited by 202
Kubo, T., Hatton, R. D., Oliver, J., Liu, X., Elson, C. O., & Weaver, C. T. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.12.7249 · Cited by 201
Acquired FV inhibitors: a needless iatrogenic complication of bovine thrombin exposure
Streiff, M. B., & Ness, P. M. (2002) · Transfusion · doi:10.1046/j.1537-2995.2002.00011.x · Cited by 199
Intravenous injection of soluble antigen induces thymic and peripheral T-cells apoptosis.
Liblau, R. S., Tisch, R., Shokat, K., Yang, X., Dumont, N., Goodnow, C. C., & McDevitt, H. O. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.7.3031 · Cited by 190
Cutting Edge: Dendritic Cells Are Sufficient to Cross-Present Self-Antigens to CD8 T Cells In Vivo
Kurts, C., Cannarile, M., Klebba, I., & Brocker, T. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.3.1439 · Cited by 184
Scientific and regulatory considerations on the immunogenicity of biologics
Shankar, G., Shores, E., Wagner, C., & Mire-Sluis, A. (2006) · Trends in Biotechnology · doi:10.1016/j.tibtech.2006.04.001 · Cited by 175
Self-citationImmunoinformatics Comes of Age
Korber, B., LaBute, M., & Yusim, K. (2006) · PLoS Computational Biology · doi:10.1371/journal.pcbi.0020071 · Cited by 175
Datta-Mannan, A., Witcher, D. R., Tang, Y., Watkins, J., & Wroblewski, V. J. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m607161200 · Cited by 170
Peerlinck, K., Arnout, J., Di Giambattista, M., Gilles, J. G., Laub, R., Jacquemin, M., Saint-Remy, J. M. R., & Vermylen, J. (1997) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1655911 · Cited by 161
The Need for Central and Peripheral Tolerance in the B Cell Repertoire
Goodnow, C. C., Adelstein, S., & Basten, A. (1990) · Science · doi:10.1126/science.2356469 · Cited by 154
Mayer, P. E., Valent, P., Schmidt, G., Liehl, E., & Bettelheim, P. (1989) · Blood · doi:10.1182/blood.v74.2.613.613 · Cited by 149
Toll-like receptors: balancing host resistance with immune tolerance
Pasare, C., & Medzhitov, R. M. (2003) · Current Opinion in Immunology · doi:10.1016/j.coi.2003.09.002 · Cited by 148
Immunogenicity of therapeutic monoclonal antibodies.
Pendley, C. E., Schantz, A., & Wagner, C. (2003) · PubMed · Cited by 147
Pure Red-Cell Aplasia and Recombinant Erythropoietin
Gershon, S. K., Luksenburg, H., Coté, T. R., & Braun, M. M. (2002) · New England Journal of Medicine · doi:10.1056/nejm200205163462015 · Cited by 143
Koren, E., Groot, A. S. D., Jawa, V., Beck, K. D., Boone, T., Rivera, D., Li, L., Mytych, D. T., Koscec, M., Weeraratne, D. K., et al. (2007) · Clinical Immunology · doi:10.1016/j.clim.2007.03.544 · Cited by 143
Ichikawa, H. T., Williams, L. P., & Segal, B. M. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.5.2781 · Cited by 139
Immunogenicity of recombinant IL-2 modified by covalent attachment of polyethylene glycol.
Katre, N. V. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.144.1.209 · Cited by 133
The Clinical Use and Immunologic Impact of Thrombin in Surgery
Lawson, J. H. (2006) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-2006-939559 · Cited by 133
Bugelski, P. J., & Treacy, G. (2004) · PubMed · Cited by 130
Prediction of immunogenicity: in silico paradigms, ex vivo and in vivo correlates
DEGROOT, A., MCMURRY, J., & MOISE, L. (2008) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2008.08.002 · Cited by 109
Single-cell dynamics of T-cell priming
Henrickson, S. E., & von Andrian, U. H. (2007) · Current Opinion in Immunology · doi:10.1016/j.coi.2007.04.013 · Cited by 101
Bennett, C. L. (2005) · Blood · doi:10.1182/blood-2005-02-0508 · Cited by 101
(2007) · PubMed · Cited by 100
Basic aspects of inhibitors to factors VIII and IX and the influence of non‐genetic risk factors
Astermark, J. (2006) · Haemophilia · doi:10.1111/j.1365-2516.2006.01360.x · Cited by 100
Clinical link between MHC class II haplotype and interferon-beta (IFN-β) immunogenicity
Barbosa, M. D. F. S., Vielmetter, J., Chu, S. Y., Smith, D. D., & Jacinto, J. M. (2005) · Clinical Immunology · doi:10.1016/j.clim.2005.08.017 · Cited by 99
Evans, G. L., & Morgan, R. A. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.10.5734 · Cited by 95
Immunogenicity of therapeutic proteins. Part 3: Impact of manufacturing changes
Sharma, B. (2007) · Biotechnology Advances · doi:10.1016/j.biotechadv.2007.01.007 · Cited by 95
de Perini, P., Facchinetti, A., Bulian, P., Massaro, A. R., de Pascalis, D., Bertolotto, A., Biasi, G., & Gallo, P. (2001) · PubMed · Cited by 94
He, X., Shaw, P., & Tam, S.-C. (1999) · Life Sciences · doi:10.1016/s0024-3205(99)00257-x · Cited by 93
Evaluation of Methods to Detect and Characterize Antibodies against Recombinant Human Erythropoietin
Swanson, S. J., Ferbas, J., Mayeux, P., & Casadevall, N. (2004) · Nephron Clinical Practice · doi:10.1159/000076746 · Cited by 93
Fineberg, N. S., Fineberg, S. E., Anderson, J. H., Birkett, M. A., Gibson, R. G., & Hufferd, S. (1996) · Diabetes · doi:10.2337/diab.45.12.1750 · Cited by 85
Immunogenicity of biopharmaceuticals in laboratory animals
Wierda, D., Smith, H. W., & Zwickl, C. M. (2001) · Toxicology · doi:10.1016/s0300-483x(00)00410-8 · Cited by 76
Self-citationBugelskil, P. J., Herzykl, D. J., Rehm, S., Harmsen, A. G., Gore, E., Williams, D. M., Maleeff, B. E., Badger, A. M., Truneh, A., O'Brien, S., et al. (2000) · Human & Experimental Toxicology · doi:10.1191/096032700678815783 · Cited by 75
Self-citationValidation of immunoassays used to assess immunogenicity to therapeutic monoclonal antibodies
Geng, D., Shankar, G., Schantz, A., Rajadhyaksha, M., Davis, H. M., & Wagner, C. L. (2005) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2005.04.045 · Cited by 71
Self-citationTatarewicz, S. M., Wei, X. L., Gupta, S., Masterman, D. M., Swanson, S. J., & Moxness, M. S. (2007) · Journal of Clinical Immunology · doi:10.1007/s10875-007-9117-8 · Cited by 69
Self-citationNeubert, H., Grace, C., Rumpel, K., & James, I. (2008) · Analytical Chemistry · doi:10.1021/ac8005439 · Cited by 66
Safety Assessment of Biotechnology-Derived Pharmaceuticals: ICH and Beyond
Serabian, M. A., & Pilaro, A. M. (1999) · Toxicologic Pathology · doi:10.1177/019262339902700106 · Cited by 63
Jaber, A., & Baker, M. (2006) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2006.10.023 · Cited by 62
Toxicity as a result of immunostimulation by biologics
Gribble, E. J., Sivakumar, P. V., Ponce, R. A., & Hughes, S. D. (2007) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.3.2.209 · Cited by 52
Self-citationScagnolari, C., Bellomi, F., Turriziani, O., Bagnato, F. R., Tomassini, V., Lavolpe, V., Ruggieri, M., Bruschi, F., Meucci, G., Dicuonzo, G., et al. (2002) · Journal of Interferon & Cytokine Research · doi:10.1089/107999002753536176 · Cited by 51
Ak, A.-A., Galazka, A., Revel, M., Biffoni, M., & Ec, B. (1997) · PubMed · Cited by 50
Antibodies as Carrier Proteins
Rehlaender, B. N., & Cho, M. J. (1998) · Pharmaceutical Research · doi:10.1023/a:1011936007457 · Cited by 44
Stickler, M. M., Valdes, A. M., Gebel, W., Razo, O. J., Faravashi, N., Chin, R., Rochanayon, N., & Harding, F. (2004) · Genes and Immunity · doi:10.1038/sj.gene.6364027 · Cited by 43
The Rebif® New Formulation Story
Jaber, A., Driebergen, R. J., Giovannoni, G., Schellekens, H., Simsarian, J., & Antonelli, M. (2007) · Drugs in R&D · doi:10.2165/00126839-200708060-00002 · Cited by 35
Levels of peripheral T cell tolerance
Arnold, B. (2002) · Transplant Immunology · doi:10.1016/s0966-3274(02)00056-4 · Cited by 35
Wood, P., & Elliott, T. J. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.4.773 · Cited by 33
Efficacy and safety of inhaled insulin in the treatment of diabetes mellitus.
de Galan, B. E., Şimşek, S., Tack, C. J., & Heine, R. J. (2006) · PubMed · Cited by 28
Dale, D. C., Nichol, J. L., Rich, D. A., Best, D. M., Slichter, S. J., Sheridan, W. P., & Hunt, P. (1997) · Blood · doi:10.1182/blood.v90.9.3456 · Cited by 25
Immunogenicity of Recombinant Human Interleukin-3
Gunn, H. (1997) · Clinical Immunology and Immunopathology · doi:10.1006/clin.1996.4302 · Cited by 18
Induction of Tolerance to Recombinant Therapeutic Proteins
Méritet, J., Maury, C., & Tovey, M. G. (2001) · Journal of Interferon & Cytokine Research · doi:10.1089/107999001317205150 · Cited by 14
Soos, J. M., Polsky, R., Keegan, S., Bugelski, P. J., & Herzyk, D. J. (2003) · Clinical Immunology · doi:10.1016/s1521-6616(03)00180-3 · Cited by 14
Self-citationIMMUNOPHARMACOLOGY OF RECOMBINANT HUMAN INTERLEUKIN-18 IN NON-HUMAN PRIMATES
Herzyk, D. J., Soos, J. M., Maier, C. C., Gore, E. R., Narayanan, P. K., Nadwodny, K. L., Liu, S., Jonak, Z., & Bugelski, P. J. (2002) · Cytokine · doi:10.1006/cyto.2002.1978 · Cited by 13
Self-citationMcGee, H. M., Scott, D. K., & Woods, G. M. (2006) · Immunology and Cell Biology · doi:10.1111/j.1440-1711.2006.01429.x · Cited by 10
Cited by
Immunogenicity to Biotherapeutics – The Role of Anti-drug Immune Complexes
Krishna, M., & Nadler, S. G. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00021 · Cited by 389
Shankar, G., Arkin, S., Cocea, L., Devanarayan, V., Kirshner, S., Kromminga, A., Quarmby, V., Richards, S., Schneider, C. K., Subramanyam, M., et al. (2014) · The AAPS Journal · doi:10.1208/s12248-014-9599-2 · Cited by 353
Self-citationImpact of Product-Related Factors on Immunogenicity of Biotherapeutics
Singh, S. K. (2011) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22276 · Cited by 350
Multispecific drugs herald a new era of biopharmaceutical innovation
Deshaies, R. J. (2020) · Nature · doi:10.1038/s41586-020-2168-1 · Cited by 262
Dong, J. Q., Salinger, D. H., Endres, C. J., Gibbs, J. P., Hsu, C.-P., Stouch, B. J., Hurh, E., & Gibbs, M. A. (2011) · Clinical Pharmacokinetics · doi:10.2165/11537430-000000000-00000 · Cited by 156
Metadata
- Authors
- Ponce, R., Abad, L., Amaravadi, L., Gelzleichter, T., Gore, E., Green, J., Gupta, S., Herzyk, D., Hurst, C., Ivens, I. A., Kawabata, T., Maier, C., Mounho, B., Rup, B., Shankar, G., Smith, H., Thomas, P., & Wierda, D.
- Venue
- Regulatory Toxicology and Pharmacology
- Publisher
- Elsevier BV
- Published
- 2009-07
- Volume
- 54
- Issue
- 2
- Pages
- 164-182
- ISSN
- 0273-2300 (ISSN-L)
- OpenAlex
- W2008716770
- Cited by
- 270
- References
- 100
- FWCI
- 8.53
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.